Court :
CESTAT, Ahmedabad
Brief :
The CESTAT, Ahmedabad in Sanofi India Limited v. C.C.E. & S.T.- SURAT-II [Excise Appeal No. 10583 of 2013 in Final Order No. A/10115-10117/2023 dated January 25, 2023] has held that, once the assessee had reversed the proportionate credit attributed to the exempted goods, no demand of 10% of the value of goods can be raised by the Revenue Department. Further held that, reversal of Cenvat credit is one of the option provided and it is upon the assessee to avail such option and the Revenue Department cannot arbitrarily choose any particular option and impose on the assessee. Remanded the matter back due to failure in examining the reversal of Cenvat credit and non-calculation of the proportionate credit. Moreover, set aside the personal penalty in the matter.
Citation :
Excise Appeal No. 10583 of 2013 in Final Order No. A/10115-10117/2023 dated January 25, 2023
Subscribe to CCI PRO for unlimited access
Already a PRO member? Login here for an ad-free experience. 07941056694
Judgement posted by
Service
FCA, FCS LLB with21 Yrs of Experience inTaxation Indirect and Direct: Education Qualification: B.Com (Hons) Chartered Accountants Company Secretary LLB Qualified SAP FI/CO Consultants Professional Membership: Chairmanof Indirect Tax Committee of PHD Chamber of Commerce Member of Indirec ... Read more
DT & Audit (Exam Oriented Fastrack Batch) - For May 26 Exams and onwards Full English